Anti-IgE in churg-strauss syndrome

Thorax

Volumn 64, Issue 3, 2009, Pages 272-

  Giavina Bianchi, P ^a   Giavina Bianchi, M ^a   Agondi, R C ^a   Kalil, J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB;

ASTHMA; CHURG STRAUSS SYNDROME; DISEASE ACTIVITY; DISEASE CONTROL; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 61649122170     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Grohé C, Tiyerili V, Pabst S. Apparent response to antiIgE therapy in two patients with refractory "forme fruste" of Churg Strauss syndrome. Thorax 2008;63:747-8.
2. Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, ef al. Administration of anti-IgE to a patient with Churg-Strauss syndrome. Int Arch Allergy Immunol 2007;144:155-8.
3. Giavina-Bianchi P, Agondi R, Kalil J. One year administration of anti-IgE to a patient with Churg-Strauss syndrome. Int Arch Allergy Immunol 2008;146:176.
4. Noga O, Hanf G, Brachmann I, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol 2006;117:1493-9.
5. Giavina-Bianchi P, Giavina-Bianchi M, et al. Omalizumab and Churg-Strauss syndrome. J Allergy Clin Immunol 2008;122:217.